Media Refuses to Cover Ivermectin Study to Combat COVID-19
>> CLICK HERE TO READ FULL ARTICLE <<
The media refuses to give any airtime to the recent study that shows very promising results surrounding the use of Ivermectin to combat COVID-19.
We are relentlessly bombarded with ads about how we should be blindly lining up to receive our ‘jab in the arm’ aka receiving the COVID vaccines to do our part to combat the pandemic.
What they don’t tell you is that all of the current COVID vaccines on the market are still being used under emergency use authorization by the FDA. Furthermore, there is very little reporting on the vast number of side effects these vaccines have been shown to cause.
We have seen two therapeutics that have proven to show promising results when battling coronavirus. One is a tried and tested medicine called hydroxychloroquine and the other is Ivermectin.
The Epoch Times reported:
A recent pre-print review based on peer-reviewed studies has found that using antiparasitic drug ivermectin could lead to “large reductions” in COVID-19 deaths and its use could have a “significant impact” on the pandemic globally.
For the study (pdf), published on June 17 in the American Journal of Therapeutics, a group of scientists reviewed the clinical trial use of ivermectin, which has antiviral and anti-inflammatory properties, in 24 randomized controlled trials involving just over 3,400 participants. The researchers sought to assess the efficacy of ivermectin in reducing infection or mortality in people with COVID-19 or at high risk of getting it.
Using multiple methods of sequential analysis, the researchers concluded with a moderate level of confidence that the drug reduced the risk of death in COVID-19 patients by an average of 62 percent, at a 95 percent confidence interval of 0.19-0.79, in a sample of 2438 patients.
Among hospitalized COVID-19 patients, the risk of death was found to be 2.3 percent among those treated with the drug, compared to 7.8 percent for those who were not, according to the review.
“Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease,” the authors wrote.
Since the start of the pandemic, both observational and randomized studies have evaluated ivermectin as a treatment for, and as prevention against, COVID-19 infection.
“A review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin ‘demonstrates a strong signal of therapeutic efficacy’ against COVID-19” the researchers wrote, referring to one recent review, which was based on data from both peer-reviewed studies and preprint manuscripts.
They cited another recent review that concluded that ivermectin reduced deaths by as much as 75 percent, while noting that neither the National Institutes of Health in the United States nor the World Health Organization (WHO) have recommended the use of ivermectin outside clinical trials for use in the fight against COVID-19.
As the debate over the use of ivermectin and other therapeutics continues on there is one aspect of this debate to keep in mind.
As with any pharmaceutical drug, manufacturers are typically in it for the money. And reports suggest that ivermectin doesn’t necessarily turn much of a profit seeing that it is an older drug. Furthermore, it is made by multiple manufacturers which both drive down the cost and reduces profits for the big pharma companies.
In a Fox News interview on ‘Sunday Morning Futures’:
Gentlemen, thank you so much for being here this morning. Good to have you both.
DR. PIERRE KORY, CRITICAL CARE AND PULMONARY MEDICINE SPECIALIST: Thank you.
BARTIROMO: And, Dr. Kory, let me play a bit of your testimony in front of Senator Johnson’s committee on treating COVID. Watch this.
KORY: Mountains of data have emerged from all — from many centers and countries around the world showing the miraculous effectiveness of ivermectin.
In early outpatient treatment, we have three randomized controlled trials and multiple observation, as well as case series, showing that, if you take ivermectin, the need for hospitalization and death will decrease.
(END VIDEO CLIP)
BARTIROMO: That was in December of 2020.
This morning, we have breaking news that everything you said was right from this new paper out of Science on this.
Senator, what happened here?
SEN. RON JOHNSON (R-WI): Well, good morning, Maria.
Well, Dr. Fauci happened. Media arrogance, social media censorship happened. That clip, that testimony from Dr. Kory, powerful testimony, was viewed by eight million Americans, who weren’t satisfied with the NIH guidelines that basically do nothing.
They wanted early treatment. It was pulled by YouTube. But we all know that Dr. Fauci, he’s not a modest man. You know, if you question what he did, apparently, you’re questioning science itself. But you can look at how he stage-managed the COVID crisis and call it anywhere close to a success; 600,000 people died, trillions of dollars of economic devastation.
He ignored early treatment. He probably helped sabotage the use of some of these things. And, Maria, you have to understand that Dr. Fauci, people in the health industries, the media, the social media, they will never admit they were wrong on this, because, if they do, they’re going to have to admit that literally hundreds of hundreds of people didn’t have to lose their lives, but for their censorship, their arrogance, and Dr. Fauci’s mismanagement.
BARTIROMO: This is unbelievable.
Dr. Kory, walk us through ivermectin. Now, ivermectin is a drug made by Merck. It has been on the market for a long time. Now this new news that we got on Friday that Fauci says they’re looking for treatments for COVID now.
One of the treatments that they’re looking at is made by Merck. So, the ivermectin Merck drug is off-patent, right? The pharma companies aren’t making any money on that because it’s off-patent. Tell us about that.
KORY: Yes, so that’s correct.
I mean, that — they do not make money off of ivermectin anymore. That’s an old drug. Many, many different manufacturers make it. Briefly, that is one of the oldest and safest drugs we have. It’s been given all around the world for decades, four billion doses.
That testimony that you played that I gave in December, the evidence was convincing then. It’s now overwhelming. Just yesterday, a paper by some of the top researchers in the world concluded that ivermectin leads to a massive reduction in the amount of patients who are dying. We’re getting reports from all over the world from Mexico that put it into their public health policy that huge numbers of patients are avoiding hospitalization and death in Argentina and in certain states in India.
We know it’s working. It’s working around the world. And nobody in the United States is hearing about it.
BARTIROMO: So, does this boil down to money then, Dr. Kory?
I mean, this drug made by Merck, ivermectin, is off-patent. They’re not making any money on it anymore. But now Fauci says he’s looking at a drug that’s going to be a patented drug made by Merck. Aren’t the underlying chemicals the same? So now they’re going to have that on patent, so that they can make a huge….
Dr Tess Lawrie : ‘’We now have all the evidence to approve Ivermectin’’ https://t.co/aYBDyJCmDM
— Craig Kelly MP (@CraigKellyMP) June 21, 2021
Linked In have just told Dr Tess Lawrie, one of the top 5% medical analysts in the country, her published review on #ivermectin goes against their policies. So Linked In, your unqualified book burning policy is to ban free speech and expert medical analysis that saves lives. pic.twitter.com/g23FmGbCD8
— Ian Harper (@IanHarper58) June 22, 2021
The money spent to ban ivermectin is way more than the money it would cost to control the entire pandemic with ivermectin.
— J Chamie (@jjchamie) June 20, 2021
**IVERMECTIN NEWS**We cannot emphasize enough the global significance of this newly published paper.
It provides the highest possible systematic review and meta-analysis for #ivermectin that leaves NO doubt whatsoever that IVM’s global adoption must be immediately implemented. https://t.co/W3ePN3EKbH
— Frontline Covid-19 Critical Care (@Covid19Critical) June 20, 2021
Would you consider taking ivermectin over trying your chances with one of the experimental vaccines?
Let us know in the comments below!
Leave a Reply